Yadav S, Dwivedi A, Tripathi A, Tripathi AK (2022a) Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders
PlexusDx supports this clarity through genetic predisposition screening and provider-guided risk assessment before treatment begins
This has prompted media and policy attention (FDAs recent crackdown on compounding pharmacies, insurer reconsideration of coverage)
In contrast, peptides whose human effects remain weak or inconsistent despite adequate exposure may warrant lower priority absent new mechanistic insights
Chang Y, Ganesh T, Horton JR, Spannhoff A, Liu J, Sun A, et al